Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2026-04-15 @ 6:39 PM
Study NCT ID:
NCT03244059
Status:
COMPLETED
Last Update Posted:
2023-07-18
First Post:
2017-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies
Sponsor:
University of Alabama at Birmingham
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-09
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-01
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-03
First Submit QC Date:
None
Study First Post Date:
2017-08-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-04-20
Results First Submit QC Date:
None
Results First Post Date:
2023-07-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-26
Last Update Post Date:
2023-07-18
Last Update Post Date Type:
ACTUAL